Growing community of inventors

Orta di Atella, Italy

Carla Cirillo

Average Co-Inventor Count = 14.99

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Carla Cirillo ↔ Antonio Calignano (1 patent)Carla Cirillo ↔ Giovanna La Rana (1 patent)Carla Cirillo ↔ Maria Grazia Rimoli (1 patent)Carla Cirillo ↔ Rosario Cuomo (1 patent)Carla Cirillo ↔ Gianpiero Boatto (1 patent)Carla Cirillo ↔ Enrico Abignente (1 patent)Carla Cirillo ↔ Daniela Melisi (1 patent)Carla Cirillo ↔ Annalisa Curcio (1 patent)Carla Cirillo ↔ Elvira Luongo (1 patent)Carla Cirillo ↔ Oscar Sasso (1 patent)Carla Cirillo ↔ Giovanni Sarnelli (1 patent)Carla Cirillo ↔ Roberto Russo (1 patent)Carla Cirillo ↔ Maria Nieddu (1 patent)Carla Cirillo ↔ Salvatore De Lucia (1 patent)Carla Cirillo ↔ Oscar Sasso (0 patent)Carla Cirillo ↔ Roberto Russo (0 patent)Carla CirilloCarla Cirillo (1 patent)Antonio CalignanoAntonio Calignano (5 patents)Giovanna La RanaGiovanna La Rana (3 patents)Maria Grazia RimoliMaria Grazia Rimoli (1 patent)Rosario CuomoRosario Cuomo (1 patent)Gianpiero BoattoGianpiero Boatto (1 patent)Enrico AbignenteEnrico Abignente (1 patent)Daniela MelisiDaniela Melisi (1 patent)Annalisa CurcioAnnalisa Curcio (1 patent)Elvira LuongoElvira Luongo (1 patent)Oscar SassoOscar Sasso (1 patent)Giovanni SarnelliGiovanni Sarnelli (1 patent)Roberto RussoRoberto Russo (1 patent)Maria NiedduMaria Nieddu (1 patent)Salvatore De LuciaSalvatore De Lucia (1 patent)Oscar SassoOscar Sasso (0 patent)Roberto RussoRoberto Russo (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (1 from 832,812 patents)

2. Stewart Italia Srl (1 from 1 patent)

3. Calignano, Antonio (0 patent)

4. Cuomo, Rosario (0 patent)

5. Boatto, Gianpiero (0 patent)

6. Rimoli, Maria Grazia (0 patent)


1 patent:

1. 8551958 - Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/19/2025
Loading…